Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies l...(ting stuff - but it begs one question. W...),Health

Good quality agency staff

The answer may lie in the additional use of good quality locum doctors. Robert Stiff is managing director of Team24, a niche recruitment consultancy that places highly skilled locum doctors - from specialist registrars to consultants - in hospitals and GP surgeries across the UK. He said: "We're already helping to fill-in gaps in rotas with good quality, specialised hospital doctors - and we've seen a huge growth over the past four years in demand for highly-skilled hospital doctors, pretty much across the UK. We foresee that this is an area that will keep growing - so we're pulling out all the stops now to recruit excellent, highly skilled locum hospital doctors so we're ready to meet that demand once 1 August arrives."

So far the directive doesn't seem to be having any negative effects at all on recruitment. In 2008 the number of junior doctors joining the NHS grew by 4.3 per cent. But the more highly skilled shifts still need filling. Robert Stiff MD Team24 added: "The Department of Health has said that meeting the requirements of the directive will give hospital trusts a great opportunity to modernise, provide improved treatment for patients, a better patient experience, and a better working environment for staff. At Team24, we see niche healthcare recruitment consultancy as playing a very important part in supporting that vision - and delivering those improvements."

Visit Team24 at www.team24.co.uk

Notes to editors - some EWTD facts and figures

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved 1 GOOD Page: 1 2 3 Related medicine news : 1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles 2. GlaxoSmithKline Responds to JAMA Articles 3. Developing a modular, nanoparticle drug delivery system 4. Voxant, the New Media Network, Distributes More Than 43,000 Health News Videos, Articles and Images 5. Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma 6. The Journal of the American Medical Association (JAMA) Article Reveals Scope of MRSA Infections 7. Mayo Clinic Proceedings article explores possible link between obesity and viral infections 8. American College of Surgeons Comments on JAMA Article on Surgeon Shortage 9. CQRC Statement on the NY Times Article on Medicares Home Oxygen Benefit 10. Statement from American Association for Homecare on New York Times Article about Home Oxygen Therapy 11. WSJ Article Prompts AHF to Renew Call for CDC to Release Stark New HIV Data Post Your Comments: *Name: *Comment: *Email: (Date:11/25/2009)...zlesmile,llc www.dazzlesmile.com andOptimalHealthS...67-pagefederallawsuitagainstEpicAdvertisingAKAAzoo...esLimited,andAtLastFulfillment.The13-countComplain...ictofUtah,allegesmassivenationalconsumerfraud,coun...oducts,violationsoftheRacketeeringInfluencedandCor... (Date:11/25/2009)...roveOverallOutcomesforLungCancer ,, WASHINGTO...rAlliance-California(LCA-CA)issuedits2ndAnnual Rep...ntofprogressbeingmadeagainstthislethaldiseaseinthe...ance(LCA),theonlynationalorganizationdedicatedexcl...ithoratriskforlungcancer. ,, (Photo: http://www... (Date:11/25/2009)...matology (ASH) is pleased to recognize the followi...bstracts in the categories of undergraduate studen...ysician, and post-doctoral,fellow. Merit Award wi...g,travel reimbursement. , The 2009 Merit Award ...imberly Fan , Donor Dendritic Cells Home to Lymph... (Date:11/25/2009)... , An innovative treatment for HIV patients dev...ers has passed its first clinical trial with flyin...stomized for each individual patient, and was deve...e of the MUHC in collaboration with Dr. R. Skaly f...ade for the individual patient an "haute couture"... (Date:11/25/2009)...atients with liver lesions, researchers find , ...ding the drug cetuximab to neoadjuvant chemotherap...ul surgery in colorectal cancer patients with inop...ests. , , Tumors spread to other parts of the ... cancer. Most commonly, the cancer spreads to the ... Breaking Medicine News(10 mins):Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:ASH announces 2009 Merit Award winners 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Cetuximab Helps Treat Colorectal Cancer 2 [0] dazzlesmile Sues Epic Advertising and Jesse Willms[0] Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer[0] ASH announces 2009 Merit Award winners[0] Tailor-made HIV/AIDS treatment closer to reality[0] Cetuximab Helps Treat Colorectal Cancer ... Unveiled at POH Riley Foundation,s Nov. 17...rysler Jeep Superstores Will Help Foundation Break...is Year,s Gala, BIRMINGHAM, Mich., Nov. 13 Needy...atrician check-ups,with the generous donation of a... ...k for obesity often focus on improving eating habi...ty. While this is one way to address the issue, an...could simply come down to positive parenting, acco... neglect in childhood and childhood obesity. Previ... ...nucleotides encoding some of the bodies, 20 amino ...normal expansion of trinucleotide repeats is the k... disorders, including Huntington disease. , Scien...of a normal repeated DNA sequence alters gene expr... ...r pancreatic surgery, most notably bleeding, infec...n can also be seen due to internal hernias or anas...wel obstruction in this setting is intussusception...ed by Dr. Luis Leons group on the November 28 issu... ...ns to deliver a comprehensive drug ...ISCO, Nov. 13 ORACLE OPENWORLD 2007 -- Tata,Consu... a leading global IT,services, business solutions ... integrated & comprehensive Drug Safety,and Pharma... ...., Nov. 13 ,PDX- NHIN and Health Market Science of...entered into an agreement to jointly market to PDX...ile(TM), a database which currently,contains over ...0071026/NEF019LOGO ) Jeff Farris, PDX-NHIN-Rx.co... Other Medicine News:Health News:Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two-Year Lease for Chrysler 300C 2Health News:Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two-Year Lease for Chrysler 300C 3Health News:A higher risk of obesity for children neglected by parents 2Health News:Antegrade bowel intussusception can cause recurrent, chronic postoperative intestinal obstruction 2Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 2Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 3Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 4Health News:PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File 2Health News:PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File 3 Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two-Year Lease for Chrysler 300CA higher risk of obesity for children neglected by parentsAbnormal glutamine repeats interfere with key transcription factor, leading to neurodegenerationAntegrade bowel intussusception can cause recurrent, chronic postoperative intestinal obstructionTCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM)PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File (Date:11/25/2009)....25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABA...arebloodanalysissystems,announcedtodaythatClintSev...atthe21stAnnualPiperJaffrayHealthCareConferenceonW...illbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...andmarketsportablebloodanalysissystemsforuseinanyv... (Date:11/25/2009)...wswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),am...inimallydisruptivesurgicaltreatmentsforthespine,an...November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfere...mentfortheCompany,sproductsandwillincludecommentsf...ion.Thedial-innumbersare1-877-407-4018fordomesticc... (Date:11/25/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...nasalDrugDelivery-USMarketTrends&Analysis htt...Delivery---US-Market-Trends--Analysis.html ,, ...ansionoftherapeuticapplicationsfromthedeliveryofco...emictherapeuticdrugs.Thefutureofthetechnologyhinge... Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Sentry Data Systems Announces Claims Guardian 28TM 29 50150 1Sentry Data Systems Announces Claims Guardian 28TM 29 50150 2Sentry Data Systems Announces Claims Guardian 28TM 29 50150 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 1Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 2Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 3 [0] Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference[0] NuVasive Announces Conference Call and Webcast Regarding Reimbursement[0] Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis ...dy Comparing Leading Hepatitis C Therapies Provide...cal Practice, MILAN, Italy, April 26 Final resul..., clinical study comparing the,leading therapies f...e 43rd,Annual Meeting of the European Association ...tant insights that may help guide clinical practic... ...ts achieve undetectable HCV RNA levels following 4...egasys(R) plus Copegus(R) -, - Safety and tolerabi...ys plus Copegus - ...bsite -, - Conference call scheduled for Friday, A... and 7:00 PM CEST (Milan) -, PRINCETON, N.J. ... Other Medicine Technology:Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 2Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 3Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 4Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 5Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 6 Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C Ultra-Sensitive Testosterone EIA ...kes it possible to determine the,vitamin levels in...es all reagents in,ready to use form for preparati... the columns. ,The advantage of HPLC analytics is ...ngle test. The HPLC complete,system enables even l... Steroid 21-Hydroxylase (21-OH) Autoantibody RIA ...st kit is intended for the quantitative determinat...eptionally sensitive ELISA procedure offers sensit...iding for accurate establishment of post-ablation ...l methods. Furthermore, with the ability to accura... Medicine Products: Ultra-Sensitive Testosterone EIAVitamin B6 (Pyridoxal-5-Phosphate) HPLC Assay KitSteroid 21-Hydroxylase (21-OH) Autoantibody RIAKRONUS META-Tg ELISA test kit Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS